Vivanza Biosciences has informed that the meeting of the Board of Directors of the Company is scheduled on 18/06/2026, to consider and approve: to authorise Sarang Bharatbhai Pathak (DIN: 02663344) to sign the Financial Statements for the financial year ended 31st March 2026 on behalf of the Board; To take note of the consent received from Dharti Shah & Co. and appoint it as an Internal Auditor of the Company for the Financial Year 2026-2027; To consider and approve the appointment of Hemant Amrish Parikh as a Non-Executive Non-Independent Director of the Company; To consider and approve the transfer of certain unverified shares to the Unclaimed Suspense Account pending verification of the identity and entitlement of the rightful shareholders and to authorize the Registrar and Share Transfer Agent to process and release such shares from the Unclaimed Suspense Account upon receipt and verification of the prescribed KYC and other supporting documents, subject to confirmation by the Company and applicable laws.
The above information is a part of company’s filings submitted to BSE.
